Has the principle of shared decision making in athletes with known cardiac abnormalities placed our athletes, teams, and medical system at risk? Are there situations where accepted medical standards and risk management trump patient autonomy? What further steps can we take to generate the data needed to ensure that the athletes we clear in the future are safe to participate? On this episode of the AMSSM Sports Medcast host Devin McFadden, MD is joined by internationally recognized expert Sanjay Sharma, MD to discuss the risks and benefits encountered while making clearance decisions in athletes with known cardiac abnormalities.